Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000239352 | SCV000296917 | uncertain significance | Hypercholesterolemia, familial, 1 | 2015-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001837789 | SCV001421317 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356336 | SCV002622351 | uncertain significance | Cardiovascular phenotype | 2016-10-21 | criteria provided, single submitter | clinical testing | The p.P1343S variant (also known as c.4027C>T), located in coding exon 25 of the APOB gene, results from a C to T substitution at nucleotide position 4027. The proline at codon 1343 is replaced by serine, an amino acid with some similar properties. This variant was previously reported in the SNPDatabase as rs374427541. Based on data from the NHLBI Exome Sequencing Project (ESP), the T allele has an overall frequency of approximately 0.01% (1/13006) total alleles studied and 0.01% (1/8600) European American alleles. Based on data from ExAC, the T allele has an overall frequency of less than 0.01% (3/106208). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |